Citations

Clear

3314 citation(s) found for "Do, Alexander".

Pain in individuals with idiopathic inflammatory myopathies, other systemic autoimmune rheumatic diseases, and without rheumatic diseases: A report from the COVAD study
Kim, Minchul , Missé, Rafael Giovani , Naveen, R, Day, Jessica , Cordeiro, Rafael Alves , Júnior, Jucier Gonçalves , Chatterjee, Tulika , Kardeş, Sinan , Milchert, Marcin , Salim, Babur , Velikova, Tsvetelina , Parodis, Ioannis , Selva-O’Callaghan, Albert , Nikiphorou, Elena , Tan, Ai Lyn , Ziadé, Nelly , Kuwana, Masataka , Nune, Arvind , Chinoy, Hector , Agarwal, Vikas , Gupta, Latika, Group, COVAD Study, Singh, Yogesh Preet , Ravichandran, Naveen , Gupta, Latika , Naveen, R , Kardes, Sinan , Gheita, Tamer , Parodis, Ioannis , Selva O'Callaghan, Albert , Saavedra, Miguel A , Ziade, Nelly , Agarwal, Vikas , Gupta, Latika , Milchert, Marcin , Day, Jessica , Velikova, Tsvetelina , Tan, Ai Lyn , Chatterjee, Tulika , Chinoy, Hector , Nune, Arvind , Singh, Yogesh Preet , Shinjo, Samuel Katsuyuki , Hoff, Leonardo Santos , Sen, Parikshit , Lilleker, James B , Agarwal, Vishwesh , Gheita, Tamer A. , Gracia‐Ramos, Abraham Edgar , Makol, Ashima , Cavagna, Lorenzo , Knitza, Johannes , Distler, Oliver , Aggarwal, Rohit , Group, COVAD Study

Mayo Clinic

International Journal of Rheumatic Diseases | March 5, 2023 | Volume: 26 | Issue: 4 | Pages: 727-739

10.1111/1756-185x.14636 | PMID 36872076 Get It

AbstractObjectivesTo compare pain intensity among individuals with idiopathic inflammatory myopathies (IIMs), other systemic autoimmune rheumatic diseases (AIRDs), and without rheumatic disease (wAIDs).MethodsData were collected from the COVID‐19 Vaccination in Autoimmune Diseases (COVAD) study, an international cross‐sectional online survey, from December 2020 to August 2021. Pain experienced in the preceding week was assessed using numeral rating scale (NRS). We performed a negative binomial regression analysis to assess pain in IIMs subtypes and whether demographics, disease activity, general health status, and physical function had an impact on pain scores.ResultsOf 6988 participants included, 15.1% had IIMs, 27.9% had other AIRDs, and 57.0% were wAIDs. The median pain NRS in patients with IIMs, other AIRDs, and wAIDs were 2.0 (interquartile range [IQR] = 1.0–5.0), 3.0 (IQR = 1.0–6.0), and 1.0 (IQR = 0–2.0), respectively (P < 0.001). Regression analysis adjusted for gender, age, and ethnicity revealed that overlap myositis and antisynthetase syndrome had the highest pain (NRS = 4.0, 95% CI = 3.5–4.5, and NRS = 3.6, 95% CI = 3.1–4.1, respectively). An additional association between pain and poor functional status was observed in all groups. Female gender was associated with higher pain scores in almost all scenarios. Increasing age was associated with higher pain NRS scores in some scenarios of disease activity, and Asian and Hispanic ethnicities had reduced pain scores in some functional status scenarios.ConclusionPatients with IIMs reported higher pain levels than wAIDs, but less than patients with other AIRDs. Pain is a disabling manifestation of IIMs and is associated with a poor functional status.
Efficacy and safety of Tuina for chronic nonspecific low back pain: A PRISMA-compliant systematic review and meta-analysis
Yang, Juan , Zhou, Xuan , Ma, Qingyu , Woods, Jeffrey , Mohabbat, Arya B. , Do, Alexander , Brault, Jeffrey S. , Jensen, Mark A. , Shin, Kyung-Min , Shen, Longbin , Zhao, Canghuan , Cheong, Philip , He, Kejie , Guo, Yu , Chen, Zhuoming , Tang, Yong , Tan, Celia Ia Choo , Bauer, Brent A. , Woods, Jeffrey T., Tang, Shujie , Chen, Jiaxu

Mayo Clinic

Medicine | March 2, 2023 | Volume: 102 | Issue: 9 | Pages: e33018

10.1097/md.0000000000033018 | PMID 36862888 Get It

Objective: Chronic nonspecific low back pain (CNLBP) is a serious medical and social problem resulting in functional decline and decreased work ability. Tuina, a form of manual therapy, has been sparsely used to treat patients with CNLBP. To systematically assess the efficacy and safety of Tuina for patients with CNLBP. Methods: Multiple English and Chinese literature databases were searched until September 2022 for randomized controlled trials (RCTs) of Tuina in the treatment of CNLBP. The methodological quality was assessed using the Cochrane Collaboration’s tool, and certainty of the evidence was determined with the online Grading of Recommendations, Assessment, Development and Evaluation tool. Results: Fifteen RCTs with 1390 patients were included. Tuina demonstrated a significant effect on pain (SMD: −0.82; 95% CI −1.12 to −0.53; P < .001; I 2 = 81%) and physical function (SMD: −0.91; 95% CI −1.55 to −0.27; P = .005; I 2 = 90%) when compared to control. However, Tuina resulted in no significant improvement for quality of life (QoL) (SMD: 0.58; 95% CI −0.04 to 1.21; P = .07; I 2 = 73%;) compared to control. The Grading of Recommendations, Assessment, Development and Evaluation evidence quality was determined to be low level for pain relief, physical function, and QoL measurements. Only six studies reported adverse events; none were serious. Conclusion: Tuina might be an effective and safe strategy for treating CNLBP in terms of pain and physical function, but not for QoL. The study results should be interpreted with caution for their low-level evidence. More multicenter, large-scale RCTs with a rigorous design are required to further confirm our findings.
Abstract PD14-05: PD14-05 Prospective longitudinal validation of a breast cancer risk prediction model in a cohort of 130,058 women
Mabey, Brent, Hughes, Elisha , Probst, Braden , Simmons, Timothy , Hullinger, Brooke, Gary, Monique, Klemp, Jennifer R. , Offit, Kenneth , Pruthi, Sandhya , Whitworth, Pat, Wagner, Susanne , Slavin, Thomas P. , Gutin, Alexander , Pederson, Holly J. , Morris, Brian, Domchek, Susan M. , Eng, Charis , Mukherjee, Semanti , Vijai, Joseph , Olopade, Olufunmilayo I. , Kurian, Allison W. , Robson, Mark E. , Lanchbury, Jerry S.

Mayo Clinic

Cancer Research | March 2, 2023 | Volume: 83 | Issue: 5_Supplement | Pages: PD14-05-PD14-05

10.1158/1538-7445.sabcs22-pd14-05 Get It

Abstract Background: Personalized breast cancer (BC) risk assessment depends on known traditional risk factors, specific germline mutations, and genome-wide polygenic risk scores (PRS). PRS explains a substantial proportion of genetic BC susceptibility. Accuracy of BC risk prediction may be improved by combining a PRS with traditional risk factors. We recently developed and validated a 149-SNP PRS for women of diverse ancestries using ancestry-informative genetic markers and combined this with version 7 of the Tyrer-Cuzick (TC) model to generate a Combined Risk Score (CRS). Here, we describe a pre-specified prospective longitudinal clinical validation of CRS as a predictor of BC risk. Methods: Women in the U.S. who were referred for clinical genetic testing between January 2017 and February 2019 were matched to medical and hospital claims in an anonymized dataset. Women with a pathogenic mutation in a BC-related gene were excluded from analysis. Follow-up began 4 months after testing and extended to the earliest date of BC diagnosis, censoring at the time of BC preventive treatment, or November 1, 2019. Incident BC events were determined by an ICD10 code of C50.* and confirmed by relevant treatment codes. CRS calibration was evaluated by the ratio of observed (O) to expected (E) incident BCs for the full cohort, and for women split into event-based 5-year CRS risk deciles. Cox proportional hazards models were used to evaluate discriminatory accuracy in terms of hazard ratios (HR) with 95% confidence intervals (CI) and p-values from likelihood ratio chi-squared statistics. Kaplan-Meier analysis was used to examine risk for women split into high- or low-risk groups according to a 3% 5-year CRS risk threshold. Results: 130,058 women with 148,349 total patient years met study eligibility criteria and were matched to claims data. Over a median (range) follow-up of 12.1 (4.0-29.5) months, 340 incident BC events were observed. The CRS was well calibrated in the overall cohort with an O/E ratio of 1.11 (95% CI=0.99-1.23) and within deciles of predicted risk (Table). Importantly, in the highest risk decile, the O/E was 0.91 (95% CI=0.63-1.27) with CRS, but 0.67 (95% CI=0.46-0.94) with TC alone, illustrating the superior calibration of CRS. In a Cox model adjusted for age at testing, PRS had an HR per standard deviation (SD) of 1.48 (95% CI=1.33-1.64, p=2.55×10-13); the HR/SD was 1.43 (95% CI=1.29-1.59, p=1.61×10-11) after adjusting for family history. In a bivariate analysis using both CRS and TC to predict time to BC, CRS added significantly to the model after accounting for TC (HR/SD=2.89, 95% CI=2.12-3.94, p=1.20×10-11), whereas TC did not add significant information after accounting for CRS. 15,986 (12.3%) women were above the CRS high-risk threshold, including 123 with events. A total of 10,248 (7.9%) women were reclassified by the CRS model compared to the TC model. Among women who were classified as high-risk by TC, 32.6% were reclassified as low-risk by CRS; among those classified as low-risk by TC, 4.3% were reclassified as high-risk by CRS. The CRS high-risk group experienced events at over three times the rate of the low-risk group (HR=3.75, 95% CI=3.00-4.68, p=6.39×10-27). Conclusion: The CRS was well-calibrated in predicting BC and significantly improved upon a traditional risk factor model. Clinical use of the CRS may lead to improved BC prevention and screening strategies. Table: Absolute risk calibration by 5-year risk decile Incidence is reported per 1,000 women-years. 34 breast cancers were observed per decile. Citation Format: Brent Mabey, Elisha Hughes, Braden Probst, Holly J. Pederson, Timothy Simmons, Brian Morris, Brooke Hullinger, Susan Domchek, Charis Eng, Monique Gary, Jennifer Klemp, Semanti Mukherjee, Vijai Joseph, Kenneth Offit, Olufunmilayo I. Olopade, Sandhya Pruthi, Allison W. Kurian, Mark E. Robson, Pat Whitworth, Susanne Wagner, Jerry Lanchbury, Thomas Slavin, Alexander Gutin. PD14-05 Prospective longitudinal validation of a breast cancer risk prediction model in a cohort of 130,058 women [abstract]. In: Proceedings of the 2022 San Antonio Breast Cancer Symposium; 2022 Dec 6-10; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2023;83(5 Suppl):Abstract nr PD14-05.
Digital Delivery of a Global Critical Care Education Program
Sun, Yuqiang, Kashyap, Rahul , Heise, Katherine J., Zambrano, Claudia Castillo , Niven, Alexander S. , Gajic, Ognjen , Dong, Yue , Castillo Zambrano, Claudia , Niven, Alexander S , Gajic, Ognjen , Kashyap, Rahul , Dong, Yue

Mayo Clinic

ATS Scholar | February 28, 2023 | Volume: 4 | Issue: 2 | Pages: 198-206

10.34197/ats-scholar.2022-0086in | PMID 37538073 Get It

Abstract Background CERTAIN (Checklist for Early Recognition and Treatment of Acute Illness and iNjury) education program was developed to accelerate the global dissemination of a standardized, systemic, structured approach to critical care delivery. The coronavirus disease (COVID-19) pandemic prompted the evolution of this program from a live in-person course to a blended synchronous and asynchronous learning experience, including virtual simulation. Objectives We describe our experience and insights gained through this digital program transformation and highlight areas in need of further research to advance the delivery of high-quality online education offerings to global interprofessional audiences. Methods The CERTAIN education program was delivered to a broad international audience first in person (2016–2019) and then virtually during the COVID-19 global pandemic (2020–present). During this transition, we adopted a flipped classroom model to deliver the core content asynchronously using an online learning management system, supplemented by a novel synchronous online experience to provide learners with the opportunity to apply these concepts using a series of simulated clinical cases. Results A total of 400 participants attended 11 CERTAIN courses. We transitioned our 10-hour live course to a 3-hour virtual workshop. The duration of simulation activities (admission, rounding, and shared decision-making) remained constant. Didactic lectures were eliminated from the synchronous online course and presented as recorded videos in precourse materials. We collected 306 postcourse surveys (response rate, 76.5%). The majority of the overall course ratings were excellent (147 [49.5%]) and very good (97 [32.7%]), and learner responses were similar to live and online courses. Simulation activities were consistently the most popular elements of our program. Access to digital learning platforms and language barriers during simulation activities proved to be the greatest challenges during our transition. Delivering mobile-friendly online content and close coordination between dedicated bilingual faculty and local champions helped overcome these challenges. Conclusion Critical care education and case-based simulation workshops can be delivered to international interprofessional audiences with similar, high degrees of learner satisfaction to in-person offerings.
The Resident Learning Journey in the Medical Intensive Care Unit
Herzog, Tyler L. , Sawatsky, Adam P. , Kelm, Diana J. , Nelson, Darlene R. , Park, John G. , Niven, Alexander S. , Niven, Alexander S

Mayo Clinic

ATS Scholar | February 28, 2023 | Volume: 4 | Issue: 2 | Pages: 177-190

10.34197/ats-scholar.2022-0103oc | PMID 37533538 Get It

Abstract Background The medical intensive care unit (MICU) offers rich resident learning opportunities, but traditional teaching strategies can be difficult to employ in this fast-paced, high-acuity environment. Resident perspectives of learning within this environment may improve our understanding of the common challenges residents face and inform novel approaches to transform the MICU educational experience. Objective We conducted a qualitative study of internal medicine residents to better understand their approach to learning the critical care activities that they are entrusted to perform in the MICU. Methods Using a thematic analysis approach, we conducted six focus group interviews with 15 internal medicine residents, separated by postgraduate year. A trained investigator led each interview, which was audio-recorded and transcribed verbatim for analysis. Our diverse research team, representing different career stages across the continuum of learning to minimize interpretive bias, identified codes and subsequent themes inductively. We refined these themes through group discussion and sensitizing social learning theory concepts using Wenger’s community of practice and organized them to create learner archetypes and a conceptual framework of resident learning in the MICU. Results We identified three thematic resident learning categories: learning goals and motivation, clinical engagement, and interprofessional collaboration. We distinguished three learner archetypes, the novice, experiential learner, and practicing member, to describe progressive resident development within the interprofessional MICU team, the challenges they frequently encounter, and potential teaching strategies to facilitate learning. Conclusion We developed a conceptual framework that describes the resident’s journey to becoming a trusted, collaborating member of the interprofessional MICU team. We identified common developmental challenges residents face and offer educational strategies that may support their progress. These findings should inform future efforts to develop novel teaching strategies to promote resident learning in the MICU.
Current opinions on DGF management practices: A survey of the United States and Canada
Hippen, Benjamin , Gill, John S. , Heilman, Raymond L. , Stewart, Darren , Reddy, Kunam S. , Mohan, Sumit , Wiseman, Alexander C. , Cooper, Matthew , Jadlowiec, Caroline , Hippen, Benjamin , Heilman, Raymond , Mohan, Sumit , Cooper, Matthew , Jadlowiec, Caroline C.

Mayo Clinic

Clinical Transplantation | February 27, 2023 | Volume: 37 | Issue: 5 | Pages: No page available

10.1111/ctr.14949 | PMID 36849704 Get It

Abstract Introduction Significant center‐to‐center variation in attitudes and management of delayed graft function (DGF) remains common. Methods A survey to describe current DGF practices was developed by workgroup members sponsored by the National Kidney Foundation (NKF) and was distributed to both the NKF DGF workgroup members, kidney transplant program directors and the transplant community within the United States and Canada. Seventy‐one percent of NKF workgroup members completed the survey along with 70 unique the United States and three Canadian kidney transplant programs. All Organ Procurement and Transplantation Network (OPTN) regions were represented. Results DGF was reported to occur at rate of 20%–40% for most centers with 3.9% indicating their incidence to be >60%. Most centers reported longer hospital lengths of stay and more frequent outpatient visits. Despite the commonality of DGF, only half of centers reported having an established protocol to manage DGF. Kidney allograft biopsies were the only consistent DGF management strategy observed, although use of machine perfusion was also heavily favored. Other DGF management strategies voiced by a minority included having established outpatient practices to care for DGF patients and administering outpatient community‐based hemodialysis. Conclusion Although approximately a third of survey responders indicated that risk of DGF played a role in their willingness to accept organs, most did not feel that increased cost or clinical impact on outcomes was a deterrent. Future strategies, including broader sharing of best practices, redefining terminology specific to DGF, the establishment of DGF dialysis guidelines and improving access to machine perfusion across OPOs may help reduce discard and improve utilization of kidneys at risk for DGF.
Analysis of Female Participant Representation in Registered Oncology Clinical Trials in the United States from 2008 to 2020
Perera, Nirosha D. , Bellomo, Tiffany R. , Schmidt, Walker M. , Litt, Henry K. , Shyu, Margaret , Stavins, MaKenna A. , Wang, Max , Bell, Alexander , Saleki, Massoud , Wolf, Katherine I. , Ionescu, Ruxandra , Tao, Jacqueline J. , OʼKeefe, Ryan , Pun, Matthew , Takasugi, Jordan M., Turner, Brandon E. , Mahipal, Amit , Wang, Max M , Ji, Sunjong , O'Keefe, Ryan M , Pun, Matthew , Steinberg, Jecca R , Turner, Brandon E , Mahipal, Amit , Bell, Alexander , Ionescu, Ruxandra, Ji, Sunjong , Go, Ronald S.

Mayo Clinic

The Oncologist | February 27, 2023 | Volume: 28 | Issue: 6 | Pages: 510-519

10.1093/oncolo/oyad009 | PMID 36848266 Get It

Abstract Background Female underrepresentation in oncology clinical trials can result in outcome disparities. We evaluated female participant representation in US oncology trials by intervention type, cancer site, and funding. Materials and Methods Data were extracted from the publicly available Aggregate Analysis of ClinicalTrials.gov database. Initially, 270,172 studies were identified. Following the exclusion of trials using Medical Subject Heading terms, manual review, those with incomplete status, non-US location, sex-specific organ cancers, or lacking participant sex data, 1650 trials consisting of 240,776 participants remained. The primary outcome was participation to prevalence ratio (PPR): percent females among trial participants divided by percent females in the disease population per US Surveillance, Epidemiology, and End Results Program data. PPRs of 0.8-1.2 reflect proportional female representation. Results Females represented 46.9% of participants (95% CI, 45.4-48.4); mean PPR for all trials was 0.912. Females were underrepresented in surgical (PPR 0.74) and other invasive (PPR 0.69) oncology trials. Among cancer sites, females were underrepresented in bladder (odds ratio [OR] 0.48, 95% CI 0.26-0.91, P = .02), head/neck (OR 0.44, 95% CI 0.29-0.68, P &lt; .01), stomach (OR 0.40, 95% CI 0.23-0.70, P &lt; .01), and esophageal (OR 0.40 95% CI 0.22-0.74, P &lt; .01) trials. Hematologic (OR 1.78, 95% CI 1.09-1.82, P &lt; .01) and pancreatic (OR 2.18, 95% CI 1.46-3.26, P &lt; .01) trials had higher odds of proportional female representation. Industry-funded trials had greater odds of proportional female representation (OR 1.41, 95% CI 1.09-1.82, P = .01) than US government and academic-funded trials. Conclusions Stakeholders should look to hematologic, pancreatic, and industry-funded cancer trials as exemplars of female participant representation and consider female representation when interpreting trial results.
Muscle activation for targeted elbow force production following surgical reconstruction in adults with brachial plexus injury
Bhat, Sandesh G. , Miller, Emily J. , Shin, Alexander Y. , Kaufman, Kenton R , Shin, Alexander Y , Miller, Emily , Bhat, Sandesh G , Kaufman, Kenton R.

Mayo Clinic

Journal of Orthopaedic Research | February 23, 2023 | Volume: 41 | Issue: 9 | Pages: 2032-2039

10.1002/jor.25534 | PMID 36815209 Get It

AbstractNerve transfer or grafting surgery to restore elbow flexion in peripheral nerve injuries has been an effective technique, but alters neuromuscular control compared with healthy individuals. This study compared neuromuscular control in the elbow flexors of 11 unimpaired control subjects and 11 adult patients with traumatic brachial plexus injury who underwent a nerve transfer or grafting procedure to the biceps motor branch to restore elbow flexion. The subjects performed a series of trials to generate a specific percentage of their maximum elbow torque. Each trial had an increasing and decreasing stairstep torque pattern that the subjects were asked to match. The amount of time that the subject's elbow torque was maintained within 5% of the target torque was calculated. The hypothesis was that there was a significant difference in the neuromuscular control between the two groups during elbow isometric torque generation. A secondary hypothesis was that a relationship existed between the neuromuscular control and the torque level for each group. The results demonstrated that neuromuscular control was different between the groups and there were significant differences in how torque levels are generated. The control group more easily modulated their myoelectric activation and achieved greater neuromuscular control variability with varying torque demand. The nerve transfer or grafting group could not modulate their myoelectric activation with changing torque demands. Further studies focusing on the improvement of neuromuscular control are needed to optimize functional outcomes in nerve injury patients.
Healthcare Resource Utilization in Patients with Newly Diagnosed Atrial Fibrillation: A Global Analysis from the GARFIELD-AF Registry
Mantovani, LG , Cozzolino, Paolo , Ferrara, Pietro , Virdone, Saverio , Camm, A. John , Verheugt, Freek W.A. , Bassand, Jean‐Pierre , Turpie, Alexander G.G., Hacke, Werner, Kayani, Gloria , Goldhaber, Samuel Z. , Goto, Shinya , Pieper, Karen S. , Haas, Sylvia , Eickels, Martin van, Kakkar, Ajay K. , Investigators, on behalf of the GARFIELD-AF, Verheugt, Freek W A , Gersh, Bernard J. , Fox, Keith A.A. , Investigators, on behalf of the GARFIELD-AF

Mayo Clinic

Healthcare | February 22, 2023 | Volume: 11 | Issue: 5 | Pages: 638

10.3390/healthcare11050638 | PMID 36900643 Get It

The management of atrial fibrillation (AF), the most common sustained arrhythmia, impacts healthcare resource utilization (HCRU). This study aims to estimate global resource use in AF patients, using the GARFIELD-AF registry. A prospective cohort study was conducted to characterize HCRU in AF patients enrolled in sequential cohorts from 2012 to 2016 in 35 countries. Components of HCRU studied were hospital admissions, outpatient care visits, and diagnostic and interventional procedures occurring during follow-up. AF-related HCRU was reported as the percentage of patients demonstrating at least one event and was quantified as rate-per-patient-per-year (PPPY) over time. A total of 49,574 patients was analyzed, having an overall median follow-up of 719 days. Almost all patients (99.5%) had at least one outpatient care visit, while hospital admissions were the second most frequent medical contact, with similar proportions in North America (37.5%) and Europe (37.2%), and slightly higher in the other GARFIELD-AF countries (42.0%; namely Australia, Egypt, and South Africa). Asia and Latin America showed lower percentages of hospitalizations, outpatient care visits, and diagnostic and interventional procedures. Analyses of GARFIELD-AF highlighted the vast AF-related HCRU, underlying significant geographical differences in the type, quantity, and frequency of AF-related HCRU. These differences were likely attributable to health service availability and differing models of care.
Racial, Ethnic, and Socioeconomic Inequities in Access to Left Atrial Appendage Occlusion
Reddy, Kriyana P. , Eberly, Lauren A. , Halaby, Rim , Julien, Howard , Khatana, Sameed Ahmed M. , Dayoub, Elias J. , Coylewright, Megan , Alkhouli, Mohamad , Fiorilli, Paul N. , Kobayashi, Taisei , Santangeli, Pasquale , Giri, Jay , Nathan, Ashwin S. , Kobayashi, Taisei J , Santangeli, Pasquale , Herrmann, Howard C , Giri, Jay , Groeneveld, Peter W , Fanaroff, Alexander C , Nathan, Ashwin S , Alkhouli, Mohamad , Goldberg, David M. , Herrmann, Howard C. , Fanaroff, Alexander C.

Mayo Clinic

Journal of the American Heart Association | February 21, 2023 | Volume: 12 | Issue: 5 | Pages: No page available

10.1161/jaha.122.028032 | PMID 36802837 Get It

Background Inequitable access to high‐technology therapeutics may perpetuate inequities in care. We examined the characteristics of US hospitals that did and did not establish left atrial appendage occlusion (LAAO) programs, the patient populations those hospitals served, and the associations between zip code–level racial, ethnic, and socioeconomic composition and rates of LAAO among Medicare beneficiaries living within large metropolitan areas with LAAO programs. Methods and Results We conducted cross‐sectional analyses of Medicare fee‐for‐service claims for beneficiaries aged 66 years or older between 2016 and 2019. We identified hospitals establishing LAAO programs during the study period. We used generalized linear mixed models to measure the association between zip code–level racial, ethnic, and socioeconomic composition and age‐adjusted rates of LAAO in the most populous 25 metropolitan areas with LAAO sites. During the study period, 507 candidate hospitals started LAAO programs, and 745 candidate hospitals did not. Most new LAAO programs opened in metropolitan areas (97.4%). Compared with non‐LAAO centers, LAAO centers treated patients with higher median household incomes (difference of $913 [95% CI, $197–$1629], P =0.01). Zip code–level rates of LAAO procedures per 100 000 Medicare beneficiaries in large metropolitan areas were 0.34% (95% CI, 0.33%–0.35%) lower for each $1000 zip code–level decrease in median household income. After adjustment for socioeconomic markers, age, and clinical comorbidities, LAAO rates were lower in zip codes with higher proportions of Black or Hispanic patients. Conclusions Growth in LAAO programs in the United States had been concentrated in metropolitan areas. LAAO centers treated wealthier patient populations in hospitals without LAAO programs. Within major metropolitan areas with LAAO programs, zip codes with higher proportions of Black and Hispanic patients and more patients experiencing socioeconomic disadvantage had lower age‐adjusted rates of LAAO. Thus, geographic proximity alone may not ensure equitable access to LAAO. Unequal access to LAAO may reflect disparities in referral patterns, rates of diagnosis, and preferences for using novel therapies experienced by racial and ethnic minority groups and patients experiencing socioeconomic disadvantage.